These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29939484)

  • 21. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
    Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
    J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulus-Responsive Smart Nanoparticles-Based CRISPR-Cas Delivery for Therapeutic Genome Editing.
    Naeem M; Hoque MZ; Ovais M; Basheer C; Ahmad I
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.
    Wang HX; Song Z; Lao YH; Xu X; Gong J; Cheng D; Chakraborty S; Park JS; Li M; Huang D; Yin L; Cheng J; Leong KW
    Proc Natl Acad Sci U S A; 2018 May; 115(19):4903-4908. PubMed ID: 29686087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-in-one individual package and delivery of CRISPR/Cas9 ribonucleoprotein using apoferritin.
    Pan X; Pei X; Huang H; Su N; Wu Z; Wu Z; Qi X
    J Control Release; 2021 Sep; 337():686-697. PubMed ID: 34389365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
    Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
    Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
    Farooq R; Hussain K; Nazir S; Javed MR; Masood N
    Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytosolic delivery of CRISPR/Cas9 ribonucleoproteins for genome editing using chitosan-coated red fluorescent protein.
    Qiao J; Sun W; Lin S; Jin R; Ma L; Liu Y
    Chem Commun (Camb); 2019 Apr; 55(32):4707-4710. PubMed ID: 30942216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Versatile Nonviral Delivery System for Multiplex Gene-Editing in the Liver.
    Gong J; Wang HX; Lao YH; Hu H; Vatan N; Guo J; Ho TC; Huang D; Li M; Shao D; Leong KW
    Adv Mater; 2020 Nov; 32(46):e2003537. PubMed ID: 33053221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple in Vivo Gene Editing via Direct Self-Assembly of Cas9 Ribonucleoprotein Complexes for Cancer Treatment.
    Kim SM; Shin SC; Kim EE; Kim SH; Park K; Oh SJ; Jang M
    ACS Nano; 2018 Aug; 12(8):7750-7760. PubMed ID: 30028587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders.
    Tan E; Wan T; Pan Q; Duan J; Zhang S; Wang R; Gao P; Lv J; Wang H; Li D; Ping Y; Cheng Y
    Sci Adv; 2024 Apr; 10(16):eadl4336. PubMed ID: 38630829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an Efficient Genome Editing Tool in Bacillus licheniformis Using CRISPR-Cas9 Nickase.
    Li K; Cai D; Wang Z; He Z; Chen S
    Appl Environ Microbiol; 2018 Mar; 84(6):. PubMed ID: 29330178
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy.
    Aziz A; Rehman U; Sheikh A; Abourehab MAS; Kesharwani P
    J Biomater Sci Polym Ed; 2023 Feb; 34(3):398-418. PubMed ID: 36083788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.
    Song M
    Biotechnol Prog; 2017 Jul; 33(4):1035-1045. PubMed ID: 28440027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.
    Chang J; Chen X; Glass Z; Gao F; Mao L; Wang M; Xu Q
    Acc Chem Res; 2019 Mar; 52(3):665-675. PubMed ID: 30586281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?
    Qiu M; Glass Z; Xu Q
    Biomacromolecules; 2019 Sep; 20(9):3333-3339. PubMed ID: 31342740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.